CCWM
CSBR icon

Cassaday & Co Wealth Management’s Champions Oncology CSBR Stock Holding History

Cassaday & Co Wealth Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62 Hold
10
– – ﹤0.01% 1292
2026
Q1 		$58 Buy
+10
New +$64 ﹤0.01% 1346

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cassaday & Co Wealth Management's CSBR Position: Q2 2026 in Review

Cassaday & Co Wealth Management held its Champions Oncology (CSBR) position steady in Q2 2026 at 10 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Cassaday & Co Wealth Management first reported a position in CSBR in Q1 2026 and has held it in 2 quarters since. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Cassaday & Co Wealth Management held 10 shares of Champions Oncology worth $62 as of Q2 2026.
  • Cassaday & Co Wealth Management left its Champions Oncology share count unchanged in Q2 2026.
  • Champions Oncology made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #1292 holding.
  • Cassaday & Co Wealth Management first reported a position in Champions Oncology in Q1 2026 and has held it in 2 quarters since.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.